Day: April 3, 2024

DALLAS, April 03, 2024 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX), a leading private markets solutions provider, today announced that its subsidiary Enhanced Capital Group LLC was named to the ImpactAssets 50™️ (IA 50) 2024, a free publicly available, searchable database of global impact investment fund managers globally. “P10 is proud of this recognition, and can speak firsthand to Enhanced Capital’s commitment to providing financing solutions to lower middle market borrowers that are seeking non-dilutive capital,” said Luke Sarsfield, P10 Chief Executive Officer. “The Enhanced Capital team pairs rigorous underwriting and a mission-driven focus across multiple asset classes to deliver solutions that seek to advance communities aligned with the UN SDG targeted outcomes.” The list is inclusive of both established and...

LONDON, April 03, 2024 (GLOBE NEWSWIRE) — Murano Global Investments Plc. (“Murano” or “Company”, Nasdaq: MRNO) announced today that its board of directors has authorized a new share repurchase program under which the Company may repurchase up to US$2 million of its ordinary shares until the end of the last business day of the third quarter in 2024, U.S. Eastern Time. The Company plans to adopt and implement this share repurchase program in accordance with applicable rules and requirements under the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policies. The Company’s proposed repurchases may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions...

MANCHESTER, N.H., April 03, 2024 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM) a global leader in power and sensing semiconductor solutions for motion control and energy-efficient systems, today announced the appointment of Jennie Raubacher to Allegro’s Board of Directors (“Board”) as an independent director. Ms. Raubacher’s appointment is effective on April 3, 2024. Jennie Raubacher joins Allegro’s Board with over 25 years of experience in investment banking focused on the semiconductor, technology and telecom sectors where she has advised global C-suite executives and boards of directors on strategic and financing transactions. Ms. Raubacher served as Managing Director at Wells Fargo & Company (“Wells Fargo”) where she led the firm’s global semiconductor and electronics investment banking practice...

Upcoming data presentations underscore the potential for FILSPARI to become a foundational treatment for IgAN and Travere’s leadership and commitment to innovation in rare kidney disease (RKD) SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present nine abstracts in rare kidney disease at the World Congress of Nephrology (WCN) in Buenos Aires, Argentina, on April 13-16, 2024, and the American Nephrology Nurses Association (ANNA) National Symposium in Orlando, Florida, on April 14-17, 2024. At WCN, the Company will present subgroup analyses of the Phase 3 PROTECT Study of FILSPARI® (sparsentan) in IgA nephropathy (IgAN) showing the treatment effect across participants with different levels of baseline proteinuria. Encore presentations will include preliminary...

CALGARY, Alberta, April 03, 2024 (GLOBE NEWSWIRE) — Precision Drilling Corporation (Precision or the Company) (TSX:PD; NYSE:PDS) announces today the filing of its Management Information Circular (the Circular) issued in connection with the 2024 Annual and Special Meeting of Shareholders (the Annual Meeting). A copy of the Circular can be downloaded from the Company’s SEDAR+ profile at www.sedarplus.ca and the Company’s EDGAR profile at www.sec.gov. The Circular is also available on Precision’s website at www.precisiondrilling.com. Precision’s Annual Meeting will be held on Thursday, May 16, 2024 at 10:00 a.m. (Mountain Time) for holders of its common shares (Shareholders). The Annual Meeting will be held in a virtual-only meeting format. The virtual-only meeting format will provide all Shareholders an equal opportunity to participate...

– Company is not offering shares pursuant to the registration statement – MELVILLE, N.Y., April 03, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced the filing of a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”). The registration statement solely covers the resale by selling securityholders of up to 2,513,686 shares of common stock of the Company that are issuable pursuant to the exercise of previously issued warrants. The filing was made pursuant to registration rights granted to the selling securityholders in connection with the issuance of the warrants to them. The Company’s Form S-1 registration statement has been filed with the...